We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBE SCIENTIFIC, LLC

Download Mobile App




New Diagnostic System Achieves PCR Testing Accuracy

By LabMedica International staff writers
Posted on 09 Apr 2024

While PCR tests are the gold standard of accuracy for virology testing, they come with limitations such as complexity, the need for skilled lab operators, and longer result times. More...

They also require complex chemical reactions which are crucial for amplifying viral DNA or RNA, a process that involves generating multiple copies of the genetic material that can also create and amplify error. Additionally, PCR tests can detect only nucleic acids, the material comprising DNA and RNA, but for certain diseases it can be of great use to detect other biomarkers such as proteins. Now, a groundbreaking diagnostic system offers the ability to accurately identify SARS-CoV-2 and Zika virus with a precision matching or surpassing that of PCR tests, but significantly reducing the time and complexity involved in diagnosis.

The new system developed at UC Santa Cruz (Santa Cruz, CA, USA) in collaboration with the Texas Biomedical Research Institute (San Antonio, TX, USA) combines optofluidics and nanopore technology to create a lab-on-a-chip diagnostic system. Optofluidics refers to the control of tiny amounts of fluids using beams of light, with a nanopore for counting single nucleic acids to read genetic material. The testing process begins with a biofluid sample mixed with magnetic microbeads designed with a matching RNA sequence of the disease for which the test is meant to detect. For instance, in case of a test to detect COVID-19, the microbeads will have strands of SARS-CoV-2 RNA on them. When SARS-CoV-2 virus is present in the sample, the virus's RNA binds to the beads.

After waiting briefly, the magnetic beads are pulled down to the bottom of the container and everything else is washed out. The beads are placed into a silicon microfluidics chip, where they flow through a long, thin channel covered by an ultra-thin membrane. The beads are caught in a light beam that pushes them against a wall in the channel, which contains a nanopore, a tiny opening only 20 nanometers across. In comparison, a human hair is approximately 80,000 - 100,000 nanometers wide. After this, heat is applied to the chip, making the RNA particles come off the beads and sucked into the nanopore, which detects that the virus RNA that is present

For this study, the researchers used various biofluids, including saliva and blood from baboons and marmosets, to understand disease transmission in different animals. The test demonstrated accuracy in virus detection at levels sometimes missed by PCR, indicating potential superior sensitivity. This lab-on-a-chip technology is not only applicable to Zika and COVID-19 but can be adapted to any virus for which the researchers have a genetic sample. The system can be further simplified and minimized, allowing it to simultaneously test for multiple disease types, a feature called disease multiplexing.

“We built up a simple lab-on-a-chip system that can perform testing at a miniature level with the help of microfluidics, silicon chips, and nanopore detection technologies,” said Mohammad Julker Neyen Sampad, a graduate student at the Texas Biomedical Research Institute. “Simple, easy, low resource tool development was our goal — and I believe we got there.”

Related Links:
UC Santa Cruz
Texas Biomedical Research Institute


New
Gold Member
Latex Test
SLE-Latex Test
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Shaking Incubator
Corning LSE 71L
New
UHF RFID Tag & Inlay
AD-327 U9 ETSI Pure 95
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Ear wax could be a possible screening medium for Parkinson’s disease (Photo courtesy of 123RF)

Earwax Test Accurately Detects Parkinson’s by Identifying Odor Molecules

Current tests for Parkinson’s disease (PD) rely heavily on clinical scales and neuroimaging, which are often subjective, expensive, and ill-suited for routine screening. Since most treatments only slow... Read more

Molecular Diagnostics

view channel
Image: Cord blood proteomics can identify biomarkers of early-onset neonatal sepsis (Photo courtesy of JCI Insight (2025). DOI: 10.1172/jci.insight.193826)

Umbilical Cord Blood Test Can Detect Early Sepsis in Preterm Infants

Diagnosing early onset sepsis (EOS) in preterm infants is particularly difficult due to the lack of specific clinical signs, leading to widespread use of antibiotics while awaiting culture results.... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: NGS can detect one tumor cell among a million healthy cells from a simple blood sample (Photo courtesy of Shutterstock)

New Tool Detects Breast Cancer Relapses Five Years in Advance

Relapse detection in patients with solid tumors—particularly hormone receptor-positive (HR+) breast cancer—remains a major clinical challenge, as many patients initially respond well to treatment but later... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.